183 related articles for article (PubMed ID: 18096507)
1. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Boon-Unge K; Yu Q; Zou T; Zhou A; Govitrapong P; Zhou J
Chem Biol; 2007 Dec; 14(12):1386-92. PubMed ID: 18096507
[TBL] [Abstract][Full Text] [Related]
2. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.
Chalfant CE; Rathman K; Pinkerman RL; Wood RE; Obeid LM; Ogretmen B; Hannun YA
J Biol Chem; 2002 Apr; 277(15):12587-95. PubMed ID: 11801602
[TBL] [Abstract][Full Text] [Related]
3. Emetine and the alternative splicing of Bcl-X: where to next?
Shultz JC; Chalfant CE
Chem Biol; 2007 Dec; 14(12):1313-4. PubMed ID: 18096499
[TBL] [Abstract][Full Text] [Related]
4. Homoharringtonine regulates the alternative splicing of Bcl-x and caspase 9 through a protein phosphatase 1-dependent mechanism.
Sun Q; Li S; Li J; Fu Q; Wang Z; Li B; Liu SS; Su Z; Song J; Lu D
BMC Complement Altern Med; 2018 May; 18(1):164. PubMed ID: 29788973
[TBL] [Abstract][Full Text] [Related]
5. Protein phosphatase 1 activation and alternative splicing of Bcl-X and Mcl-1 by EGCG + ibuprofen.
Kim MH
J Cell Biochem; 2008 Jul; 104(4):1491-9. PubMed ID: 18348186
[TBL] [Abstract][Full Text] [Related]
6. Emetine regulates the alternative splicing of caspase 9 in tumor cells.
Pan D; Boon-Unge K; Govitrapong P; Zhou J
Oncol Lett; 2011 Nov; 2(6):1309-1312. PubMed ID: 22848307
[TBL] [Abstract][Full Text] [Related]
7. NHE3 function and phosphorylation are regulated by a calyculin A-sensitive phosphatase.
Dynia DW; Steinmetz AG; Kocinsky HS
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F745-53. PubMed ID: 20015946
[TBL] [Abstract][Full Text] [Related]
8. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
[TBL] [Abstract][Full Text] [Related]
9. A G-tract element in apoptotic agents-induced alternative splicing.
Hai Y; Cao W; Liu G; Hong SP; Elela SA; Klinck R; Chu J; Xie J
Nucleic Acids Res; 2008 Jun; 36(10):3320-31. PubMed ID: 18440980
[TBL] [Abstract][Full Text] [Related]
10. PP1/PP2A phosphatase inhibition-induced metaplasticity in protein synthesis blocker-treated hippocampal slices: LTP and LTD, or There and Back again.
Maltsev AV; Balaban PM
Biochem Biophys Res Commun; 2021 Jun; 558():64-70. PubMed ID: 33901925
[TBL] [Abstract][Full Text] [Related]
11. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
12. Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion.
Gu J; Wang W; Miao S; Chen F; Wu F; Hu W; Iqbal K; Gong CX; Liu F
FEBS Lett; 2018 Feb; 592(3):402-410. PubMed ID: 29334120
[TBL] [Abstract][Full Text] [Related]
13. The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL.
Sun Q; Yogosawa S; Iizumi Y; Sakai T; Sowa Y
Int J Oncol; 2015 Jan; 46(1):389-94. PubMed ID: 25310746
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin.
Favre B; Turowski P; Hemmings BA
J Biol Chem; 1997 May; 272(21):13856-63. PubMed ID: 9153244
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia.
Willimott S; Merriam T; Wagner SD
Biochem Biophys Res Commun; 2011 Feb; 405(3):480-5. PubMed ID: 21256112
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells.
Liu L; Huang Z; Chen J; Wang J; Wang S
J Cell Biochem; 2018 Aug; 119(8):6633-6643. PubMed ID: 29693750
[TBL] [Abstract][Full Text] [Related]
17. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
18. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.
Mercatante DR; Mohler JL; Kole R
J Biol Chem; 2002 Dec; 277(51):49374-82. PubMed ID: 12381725
[TBL] [Abstract][Full Text] [Related]
19. Modification of alternative splicing of Bcl-x pre-mRNA in bladder cancer cells.
Zhu Z; Xing S; Cheng P; Zeng F; Lu G
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):213-6. PubMed ID: 16850750
[TBL] [Abstract][Full Text] [Related]
20. Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib.
Chang WH; Liu TC; Yang WK; Lee CC; Lin YH; Chen TY; Chang JG
Cancer Res; 2011 Jan; 71(2):383-92. PubMed ID: 21224352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
